Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials. While stem cell therapies can be effective, they are also associated with some risks of both tumor growth and immune rejection. Also, the cells themselves are very fragile, requiring careful storage and a multi-step process of typing and characterization before they can be used.
Ke Cheng, associate professor of molecular biomedical sciences at NC State, associate professor in the joint biomedical engineering program at NC State and UNC, and adjunct associate professor at the UNC Eshelman School of Pharmacy, led a team in developing the synthetic version of a cardiac stem cell that could be used in off-the-shelf applications.
Cheng and his colleagues fabricated a cell-mimicking microparticle (CMMP) from poly (lactic-co-glycolic acid) or PLGA, a biodegradable and biocompatible polymer. The researchers then harvested growth factor proteins from cultured human cardiac stem cells and added them to the PLGA. Finally, they coated the particle with cardiac stem cell membrane.
“We took the cargo and the shell of the stem cell and packaged it into a biodegradable particle,” Cheng says.
When tested in vitro, both the CMMP and cardiac stem cell promoted the growth of cardiac muscle cells. They also tested the CMMP in a mouse model with myocardial infarction, and found that its ability to bind to cardiac tissue and promote growth after a heart attack was comparable to that of cardiac stem cells. Due to its structure, CMMP cannot replicate – reducing the risk of tumor formation.
“The synthetic cells operate much the same way a deactivated vaccine works,” Cheng says. “Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.”
The synthetic stem cells are much more durable than human stem cells, and can tolerate harsh freezing and thawing. They also don’t have to be derived from the patient’s own cells. And the manufacturing process can be used with any type of stem cell.
“We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they’re needed, without costly delays,” Cheng says.
Receive an email update when we add a new STEM CELLS article.
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Global Stem Cell Therapy Market Is Estimated to...on July 5, 2019 at 3:41 am
PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Stem Cell Therapy Industry was valued at USD 105.24 Million in the year 2017. Global Stem Cell Therapy Industry is further estimated to grow at a ... […]
- Neural crest stem cells from human epidermis of aged donors maintain their multipotency in vitro and in vivoon July 5, 2019 at 3:19 am
Neural crest (NC) cells are multipotent stem cells that arise from the embryonic ectoderm, delaminate from the neural tube in early vertebrate development and migrate throughout the developing embryo, ... […]
- AWD regulates timed activation of BMP signaling in intestinal stem cells to maintain tissue homeostasison July 5, 2019 at 2:18 am
Precise control of stem cell (SC) proliferation ensures tissue homeostasis. In the Drosophila intestine, injury-induced regeneration involves initial activation of intestinal SC (ISC) proliferation ... […]
- Glasgow Researchers Explore Stem Cell Engineering with Bacteria Filled Microgelson July 5, 2019 at 2:07 am
Researchers from University of Glasgow are expanding their research into bioprinting, with their findings outlined in the recently published ‘Bacteria laden microgels as autonomous 3D ... […]
- Can Stem Cells be Used to Treat Epilepsy?on July 4, 2019 at 11:04 pm
Epilepsy is a neurological condition characterised by recurrent episodes of seizures. Most cases of epilepsy do not have a clear known cause, apart from susceptible genetic factors. The primary ... […]
- Scientists discover new way to direct stem cells to heart tissueon July 3, 2019 at 9:38 pm
In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could radically ... […]
- Will California Voters Be Stem-Cell Suckered Again?on July 3, 2019 at 10:49 am
Back in 2004, the university-biotech complex and its camp followers in the media and Hollywood convinced California voters to borrow $3 Billion to establish the California Institute for Regenerative ... […]
- Artificial membrane binding proteins to direct stem cells to the myocardiumon July 3, 2019 at 6:19 am
In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could ... […]
- A Bulwark against Trump's Stem Cell Banon July 2, 2019 at 9:04 am
My commute begins each morning when I get on the N-line MUNI, one of San Francisco's oldest remaining streetcar lines that winds its way through the city's sleepy Outer Sunset district. A blur of ... […]
via Bing News